- Home
- BFRI vs DSS Comparison
BFRI vs DSS Comparison
Compare BFRI & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- DSS
- Stock Information
- Founded
- BFRI 1997
- DSS 1984
- Country
- BFRI United States
- DSS United States
- Employees
- BFRI N/A
- DSS N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- BFRI Health Care
- DSS Consumer Discretionary
- Exchange
- BFRI Nasdaq
- DSS Nasdaq
- Market Cap
- BFRI 11.1M
- DSS 11.7M
- IPO Year
- BFRI 2021
- DSS N/A
- Fundamental
- Price
- BFRI $0.88
- DSS $1.02
- Analyst Decision
- BFRI Strong Buy
- DSS
- Analyst Count
- BFRI 1
- DSS 0
- Target Price
- BFRI $2.75
- DSS N/A
- AVG Volume (30 Days)
- BFRI 201.2K
- DSS 60.1K
- Earning Date
- BFRI 11-12-2025
- DSS 11-14-2025
- Dividend Yield
- BFRI N/A
- DSS N/A
- EPS Growth
- BFRI N/A
- DSS N/A
- EPS
- BFRI N/A
- DSS N/A
- Revenue
- BFRI $37,164,000.00
- DSS $22,046,000.00
- Revenue This Year
- BFRI $9.70
- DSS N/A
- Revenue Next Year
- BFRI $12.58
- DSS N/A
- P/E Ratio
- BFRI N/A
- DSS N/A
- Revenue Growth
- BFRI 5.11
- DSS 6.53
- 52 Week Low
- BFRI $0.54
- DSS $0.72
- 52 Week High
- BFRI $1.87
- DSS $1.90
- Technical
- Relative Strength Index (RSI)
- BFRI 37.83
- DSS 34.10
- Support Level
- BFRI $0.80
- DSS $1.00
- Resistance Level
- BFRI $1.13
- DSS $1.25
- Average True Range (ATR)
- BFRI 0.10
- DSS 0.09
- MACD
- BFRI -0.03
- DSS -0.01
- Stochastic Oscillator
- BFRI 16.95
- DSS 20.07
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.